CASI: CASI Pharmaceuticals, Inc. Stock

by  •  • Comments Off on CASI: CASI Pharmaceuticals, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 29.90
Enterprise Value ($M) 53.94
Book Value ($M) 1.85
Book Value / Share 0.12
Price / Book 16.15
NCAV ($M) -12.25
NCAV / Share -0.79
Price / NCAV -2.44

Profitability (mra)
Return on Invested Capital (ROIC) -0.91
Return on Assets (ROA) -0.68
Return on Equity (ROE) -2.54

Liquidity (mrq)
Quick Ratio 0.94
Current Ratio 1.09

Balance Sheet (mrq) ($M)
Current Assets 39.58
Assets 53.67
Liabilities 51.82
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 28.54
Operating Income -39.21
Net Income -39.26
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -29.22
Cash from Investing 11.24
Cash from Financing 15.43

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-03 13D/A Idg-accel China Growth Fund Iii L.p. 6.40
10-29 13G/A Huang James 9.20 26.99
08-12 13D/A He Wei-Wu 20.94 14.80
07-25 13G Venrock Healthcare Capital Partners III, L.P. 9.99
06-20 13G Foresite Capital Fund VI LP 9.80

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 5,231 16,796 31.14
2025-04-16 619 4,490 13.79
2025-04-15 960 4,339 22.12
2025-04-14 7,230 32,773 22.06

(click for more detail)

Similar Companies
BYSI – BeyondSpring Inc. CALC – CalciMedica, Inc.
CAPR – Capricor Therapeutics, Inc. CDIO – Cardio Diagnostics Holdings, Inc.
CDTX – Cidara Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io